Clinical Utility of Urinary Liver‐Type Fatty Acid‐Binding Protein Measured via Point‐of‐Care Testing in Acute Kidney Injury After Transcatheter Aortic Valve Implantation
Nephrology · 2026-04 · 31 (4)
DOI: 10.1111/nep.70200 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Nephrology, online erschienen am 06.04.2026. Verfasst von Yumi Obata und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan. Hauptthemen laut MEDLINE: Fatty Acid-Binding Proteins, Acute Kidney Injury, Point-of-Care Testing, Transcatheter Aortic Valve Replacement. Die Arbeit nennt 27 Literaturangaben.
Abstract (Originalsprache)
Aim
This study evaluated the clinical usefulness of urinary liver‐type fatty acid‐binding protein (L‐FABP) measured via point‐of‐care testing (POCT) based on immunochromatography for the early prediction of acute kidney injury (AKI) following transcatheter aortic valve implantation (TAVI).
Methods
This retrospective observational study was conducted at a single‐centre university hospital and included 186 patients who underwent TAVI. The onset of AKI was defined according to the Acute Kidney Injury Network classification. Urine samples were collected preoperatively, immediately after surgery, 4 h postoperatively and on postoperative days 1, 2 and 3 to measure urinary L‐FABP using POCT.
Results
Of the 186 patients who underwent TAVI, 24 (12.9%) developed AKI postoperatively. Patients with AKI exhibited a decreased left ventricular ejection fraction, the co‐occurrence of both hypertension and advanced‐stage chronic kidney disease and a longer hospital stay. During the observational period, patients with AKI were found to have significantly higher urinary L‐FABP levels than those without. Preoperative urinary L‐FABP showed the highest predictive performance for AKI onset, with an area under the receiver operating characteristic curve of 0.74 (cutoff value, 4.24 ng/mL; sensitivity, 0.61; specificity, 0.82; diagnostic accuracy, 0.79). Elevated urinary L‐FABP levels above the cutoff value in the early phase of the perioperative period independently predicted AKI onset after adjusting for ejection fraction and the presence of renal dysfunction in the multivariable logistic regression analysis.
Conclusion
This study indicated for the first time that urinary L‐FABP levels measured via POCT were independently associated with the development of AKI following TAVI, indicating potential utility for early risk assessment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.
- Department of Anatomy, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.
- Department of Nephrology and Hypertension, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.
ORCID-Profile: Yumi Obata
Zitieren
APA
Obata, Y., Kamijo-Ikemori, A., Shimmi, S., Ohata, K., Sugaya, T., & Inoue, S. (2026). Clinical Utility of Urinary Liver‐Type Fatty Acid‐Binding Protein Measured via Point‐of‐Care Testing in Acute Kidney Injury After Transcatheter Aortic Valve Implantation. Nephrology, 31(4). https://doi.org/10.1111/nep.70200
Vancouver
Obata Y, Kamijo-Ikemori A, Shimmi S, Ohata K, Sugaya T, Inoue S. Clinical Utility of Urinary Liver‐Type Fatty Acid‐Binding Protein Measured via Point‐of‐Care Testing in Acute Kidney Injury After Transcatheter Aortic Valve Implantation. Nephrology. 2026;31(4). doi:10.1111/nep.70200
BibTeX
@article{Obata2026,
author = {Obata, Yumi and Kamijo-Ikemori, Atsuko and Shimmi, Sachi and Ohata, Keiichi and Sugaya, Takeshi and Inoue, Soichiro},
title = {Clinical Utility of Urinary Liver‐Type Fatty Acid‐Binding Protein Measured via Point‐of‐Care Testing in Acute Kidney Injury After Transcatheter Aortic Valve Implantation},
journal = {Nephrology},
year = {2026},
volume = {31},
number = {4},
doi = {10.1111/nep.70200}
}
EUVIMED